Repeated courses of certain antibiotics associated with increased diabetes risk

Share this content:

the ONA take:

Repeated use of penicillins, cephalosporins, quinolones, and macrolides may increase people's risk of developing type 2 diabetes by changing their gut flora, a recent study published in the European Journal of Endocrinology has shown.

Researchers from the Departments of Gastroenterology and Medical Oncology at the University of Pennsylvania in Philadelphia, Pennsylvania, analyzed data from over 200,000 diabetics in the UK prescribed antibiotics in the years before diagnosis and compared the number of antibiotic prescriptions to the number prescribed to 800,000 non-diabetics.

Results showed that patients who were prescribed at least two courses of penicillins, cephalosporins, quinolones, and macrolides were at an increased risk of being diagnosed with type 2 diabetes.

Researchers also found that the risk increased with repeated antibiotic courses. The researchers suggest that the association between antibiotic use and diabetes may be due to antibiotics altering the diversity of gut bacteria.

Researchers found no that suggests anti-virals or anti-fungals increase the risk of type 2 diabetes and minimal evidence to support a link between antibiotics and an increased risk of type 1 diabetes.

The findings emphasize the necessity to decrease the number of unnecessary antibiotic prescriptions.

Some antibiotics tied to increased colon cancer risk
Repeated use of antibiotics may increase people's risk of developing type 2 diabetes by changing their gut flora.
Repeated use of some types of antibiotics may put people at increased risk of developing type-2 diabetes by possibly altering their gut bacteria, according to a large observational study published today in the European Journal of Endocrinology.
READ FULL ARTICLE From Medical Express
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs